newsfilter
← Latest News
GlobeNewswire·

LAVA Therapeutics Announces Appointment of New Directors to the Board

UTRECHT, The Netherlands and PHILADELPHIA, Jan. 06, 2023 (GLOBE NEWSWIRE) -- LAVA Therapeutics N.V. (NASDAQ:LVTX), a clinical-stage immuno-oncology company focused on developing its proprietary Gammabody™